Moderate Sedation for Elective Upper Endoscopy With Balanced Propofol Versus Propofol Alone: a Randomized Clinical Trial

• Status: Completed
• Trial end date: 2015-02-04
• Target enrollment: 0
• Participant gender: All

Summary

Since introduction in 1989, propofol has gained wide acceptance for sedation during endoscopic procedures. The optimal sedation drug during esophagogastroendoscopy (EGD) is not established. Midazolam and propofol are used for sedation drug. Balanced propofol sedation (BPS) refers to the administration of an opiate, a benzodiazepine, and propofol. In this study, the investigators want to compare the patient satisfaction with EGD following balanced propofol sedation (BPS) versus propofol sedation alone.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Yonsei University
• Treatments: Midazolam; Propofol

Criteria

Inclusion Criteria:

1. over 19 years old, male and female

2. patients who have plan to get esophagogastroduodenoscopy (EGD)

Exclusion Criteria:

1. ASA class III or IV

2. Allergies to propofol, sulfites or eggs

3. patients who had surgery for esophagus, stomach or duodenum

4. inpatients

5. patients who had sleep apnea, gastroparesis or achalasia

6. patients who are taking sedative drugs more than 6 months

7. pregnancy

8. hypotension (systolic pressure less than 90mmHg), bradycardia (pulse rates less than 50 times per minute) or hypoxia (SpO2 less than 90%)

9. psychiatric or neurologic problems (ex. epilepsy or dementia)